333D Ltd Posts 15.7% Revenue Growth, Raises $1M, and Builds Bitcoin Treasury
333D Ltd reports a fifth consecutive quarter of revenue growth, secures $1 million in fresh capital, and expands its blockchain healthcare initiatives while building a strategic Bitcoin treasury.
- 15.7% quarterly revenue growth in digital asset management
- Raised $1 million via placement to sophisticated investors
- Invested in Bitcoin treasury valued at AUD 356,784
- Received $413,773 R&D tax incentive from Australian Taxation Office
- Launched pilot collaboration with BioScan 360 for blockchain-based MRI data
Sustained Revenue Momentum
333D Ltd (ASX, T3D) has reported a robust quarter ending 30 September 2025, marking its fifth consecutive quarter of growth in digital asset management revenues. The company generated $318,431 in cash receipts from customers, reflecting a 15.69% increase over the previous quarter. This growth underscores the success of 333D’s strategic pivot towards providing digital asset management services tailored to the healthcare sector.
Capital Raise and Financial Position
During the quarter, 333D completed a placement raising $1 million from sophisticated investors at $0.10 per share, netting $970,000 after costs. This capital injection bolsters the company’s balance sheet, complementing a healthy cash balance of $835,508 at quarter-end. The company also reported net operating cash inflows of $160,742, a significant turnaround from the previous quarter’s slight cash burn.
Strategic Bitcoin Treasury Investment
In a notable move, 333D acquired over 2 Bitcoins during the quarter, valued at AUD 356,784, as part of its Bitcoin Treasury Management Policy. This initiative aims to leverage excess cash reserves to build a long-term strategic holding in Bitcoin, potentially supporting future acquisitions and growth initiatives. The company’s engagement with cryptocurrency is further highlighted by its directors’ participation in major international conferences focused on Bitcoin, AI, and digital assets.
Innovation in Healthcare Blockchain
333D is advancing its footprint in the healthcare sector through a pilot collaboration with BioScan 360, announced shortly after the quarter’s end. This project involves recording full-body MRI scan data on the blockchain, enabling decentralized, secure storage and giving patients auditable ownership of their medical data. If successful, 333D plans to scale this service nationally, positioning itself at the forefront of preventative healthcare technology.
Ongoing R&D and Industry Engagement
The company’s commitment to innovation is further evidenced by the receipt of a $413,773 R&D tax incentive from the Australian Taxation Office, reflecting ongoing research and development efforts. Additionally, 333D’s directors are actively engaging with the global digital asset and AI communities, with upcoming presentations at prominent events such as the Australian Crypto Convention and the Cantor Fitzgerald Crypto & AI/Energy Infrastructure Conference.
Bottom Line?
With fresh capital, strategic Bitcoin holdings, and pioneering blockchain healthcare projects, 333D Ltd is poised for a transformative phase; investors will be watching closely for the next milestones.
Questions in the middle?
- How will the Bitcoin treasury impact 333D’s financial stability amid cryptocurrency volatility?
- What are the expected timelines and success metrics for the BioScan 360 blockchain pilot?
- Can 333D sustain its revenue growth trajectory as it scales digital asset management services nationally?
